ROIV
Roivant's first quarter EPS beats estimates on lower-than-expected loss, while its cash position remains strong at $3.9B.
Roivant Sciences reported a first quarter net loss of $0.26 per share, narrower than analyst expectations, on revenue of $1.4 million which missed estimates....